New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Discovery unveils immune system's guardian: Ikaros

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia
Immunology & Rheumatology January 26,2024
Discovery unveils immune system's guardian: Ikaros

Discovery unveils immune system's guardian: Ikaros

byMonash UniversityCredit: Pixabay/CC0 Public DomainIn a scientific breakthrough that aids our understanding of the internal wiring of immune cells, researchers at Monash University in Australia
Immunology & Rheumatology January 26,2024
New weight-loss drug Zepbound is now available, company says

New weight-loss drug Zepbound is now available, company says

by Robin FosterThe newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday."Today opens another chapter for adults li
Breakthroughs January 26,2024
New weight-loss drug Zepbound is now available, company says

New weight-loss drug Zepbound is now available, company says

by Robin FosterThe newly approved weight-loss medication known as Zepbound is now available for patients to take, drug maker Eli Lilly announced Tuesday."Today opens another chapter for adults li
Breakthroughs January 26,2024
States strive to get opioid overdose drug to more people

States strive to get opioid overdose drug to more people

by Anna Claire Vollers, Stateline.orgCredit: Unsplash/CC0 Public DomainPosing as shoppers, a team of researchers from the University of Mississippi called nearly 600 pharmacies across the state and as
Breakthroughs January 26,2024
States strive to get opioid overdose drug to more people

States strive to get opioid overdose drug to more people

by Anna Claire Vollers, Stateline.orgCredit: Unsplash/CC0 Public DomainPosing as shoppers, a team of researchers from the University of Mississippi called nearly 600 pharmacies across the state and as
Breakthroughs January 26,2024
How first contact influences the immune response to new SARS-CoV-2 variants

How first contact influences the immune response to new SARS-CoV-2 variants

byUniversity of CologneGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.004Although SARS-CoV-2 is no longer a stranger to the immune system, new virus variant
Public Health & Prevention January 26,2024
How first contact influences the immune response to new SARS-CoV-2 variants

How first contact influences the immune response to new SARS-CoV-2 variants

byUniversity of CologneGraphical abstract. Credit:Immunity(2023). DOI: 10.1016/j.immuni.2023.11.004Although SARS-CoV-2 is no longer a stranger to the immune system, new virus variant
Public Health & Prevention January 26,2024
Using mice with humanized immune systems to test cancer immunotherapies

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di
Oncology January 26,2024
Using mice with humanized immune systems to test cancer immunotherapies

Using mice with humanized immune systems to test cancer immunotherapies

byKobe UniversityCurrently developed cancer immunotherapies modify the interaction of cancer cells and the immune system, making drug testing targeting human cancer outside of clinical trials di
Oncology January 26,2024
Pharmacologic restraint used in 3 percent of pediatric mental health admissions

Pharmacologic restraint used in 3 percent of pediatric mental health admissions

by Elana GotkineThe use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11
Breakthroughs January 26,2024
Pharmacologic restraint used in 3 percent of pediatric mental health admissions

Pharmacologic restraint used in 3 percent of pediatric mental health admissions

by Elana GotkineThe use of pharmacologic restraints occurs in 3 percent of hospitalizations for children admitted with a primary mental health diagnosis, according to a study published online Dec. 11
Breakthroughs January 26,2024
Drug-drug interactions seen in 21.4% of children with medication exposure

Drug-drug interactions seen in 21.4% of children with medication exposure

by Elana GotkineMore than 20% of children with two or more medication exposures experience major drug-drug interactions (DDIs) annually, according to a study published online Jan. 4 inPediatrics
Breakthroughs January 26,2024
Drug-drug interactions seen in 21.4% of children with medication exposure

Drug-drug interactions seen in 21.4% of children with medication exposure

by Elana GotkineMore than 20% of children with two or more medication exposures experience major drug-drug interactions (DDIs) annually, according to a study published online Jan. 4 inPediatrics
Breakthroughs January 26,2024
Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t
Oncology January 26,2024
Cell therapy appears safe and effective for lymphoma in remission

Cell therapy appears safe and effective for lymphoma in remission

byUniversity of Miami Leonard M. Miller School of MedicineCredit: University of Miami Leonard M. Miller School of MedicineA study led by researchers at Sylvester Comprehensive Cancer Center at t
Oncology January 26,2024
Patients regain much weight after stopping new obesity drug: Study

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On
Breakthroughs January 26,2024
Patients regain much weight after stopping new obesity drug: Study

Patients regain much weight after stopping new obesity drug: Study

This is an image of a weight scale. Credit: CDC/Debora CartagenaA new generation of obesity drugs often delivers dramatic weight loss, but many patients wonder what happens when they stop treatment.On
Breakthroughs January 26,2024
COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

byPasteur InstituteThe study showed that the SARS-CoV-2 virus is transmitted from one macrophage to another via bridge-like cellular projections, enabling it to spread. The cell nucleus is highl
Public Health & Prevention January 26,2024
COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

COVID-19: The persistence of SARS-CoV-2 in the lungs and the role of innate immunity

byPasteur InstituteThe study showed that the SARS-CoV-2 virus is transmitted from one macrophage to another via bridge-like cellular projections, enabling it to spread. The cell nucleus is highl
Public Health & Prevention January 26,2024
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com